| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |